 Treatment Outcome
"Treatment Outcome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, practicability, etc., of these interventions in individual cases or series.
| Descriptor ID |
D016896
|
| MeSH Number(s) |
E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Treatment Outcome".
Below are MeSH descriptors whose meaning is more specific than "Treatment Outcome".
This graph shows the total number of publications written about "Treatment Outcome" by people in this website by year, and whether "Treatment Outcome" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 1 | 8 | 9 | | 1992 | 0 | 11 | 11 | | 1993 | 1 | 24 | 25 | | 1994 | 0 | 36 | 36 | | 1995 | 0 | 41 | 41 | | 1996 | 0 | 54 | 54 | | 1997 | 1 | 68 | 69 | | 1998 | 1 | 84 | 85 | | 1999 | 1 | 78 | 79 | | 2000 | 0 | 92 | 92 | | 2001 | 0 | 123 | 123 | | 2002 | 0 | 115 | 115 | | 2003 | 2 | 144 | 146 | | 2004 | 0 | 160 | 160 | | 2005 | 4 | 192 | 196 | | 2006 | 1 | 200 | 201 | | 2007 | 0 | 249 | 249 | | 2008 | 1 | 229 | 230 | | 2009 | 4 | 262 | 266 | | 2010 | 0 | 286 | 286 | | 2011 | 1 | 318 | 319 | | 2012 | 2 | 286 | 288 | | 2013 | 3 | 304 | 307 | | 2014 | 0 | 294 | 294 | | 2015 | 1 | 278 | 279 | | 2016 | 2 | 318 | 320 | | 2017 | 1 | 284 | 285 | | 2018 | 2 | 310 | 312 | | 2019 | 1 | 308 | 309 | | 2020 | 1 | 267 | 268 | | 2021 | 0 | 212 | 212 | | 2022 | 0 | 77 | 77 |
To return to the timeline, click here.
Below are the most recent publications written about "Treatment Outcome" by people in Profiles.
-
Ettleson MD, Bianco AC, Wan W, Laiteerapong N. Suboptimal Thyroid Hormone Replacement Is Associated With Worse Hospital Outcomes. J Clin Endocrinol Metab. 2022 07 14; 107(8):e3411-e3419.
-
Jakubowiak AJ, Kumar S, Medhekar R, Pei H, Lefebvre P, Kaila S, He J, Lafeuille MH, Cortoos A, Londhe A, Mavros P, Lin TS, Usmani SZ. Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma. Oncologist. 2022 Jul 05; 27(7):e589-e596.
-
Major A, Kline J, Karrison TG, Fishkin PAS, Kimball AS, Petrich AM, Nattam S, Rao K, Sleckman BG, Cohen K, Besien KV, Rapoport AP, Smith SM. Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas. Haematologica. 2022 Jul 01; 107(7):1608-1618.
-
Gordon KB, Langley RG, Warren RB, Okubo Y, Stein Gold L, Merola JF, Peterson L, Wixted K, Cross N, Deherder D, Thaçi D. Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis: Pooled Results From Phase 2 and Phase 3 Randomized Clinical Trials. JAMA Dermatol. 2022 07 01; 158(7):735-744.
-
Weber P, Amin S, Qiu M. Decompression Retinopathy after Ahmed Glaucoma Valve in a Patient with Neurofibromatosis Type 1 and Moyamoya Syndrome. Ophthalmology. 2022 07; 129(7):802.
-
Nicholson MR, Alexander E, Ballal S, Davidovics Z, Docktor M, Dole M, Gisser JM, Goyal A, Hourigan SK, Jensen MK, Kaplan JL, Kellermayer R, Kelsen JR, Kennedy MA, Khanna S, Knackstedt ED, Lentine J, Lewis JD, Michail S, Mitchell PD, Oliva-Hemker M, Patton T, Queliza K, Sidhu S, Solomon AB, Suskind DL, Weatherly M, Werlin S, de Zoeten EF, Kahn SA. Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease. J Crohns Colitis. 2022 Jun 24; 16(5):768-777.
-
Sands BE, Irving PM, Hoops T, Izanec JL, Gao LL, Gasink C, Greenspan A, Allez M, Danese S, Hanauer SB, Jairath V, Kuehbacher T, Lewis JD, Loftus EV, Mihaly E, Panaccione R, Scherl E, Shchukina OB, Sandborn WJ. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial. Lancet. 2022 06 11; 399(10342):2200-2211.
-
Visco DM, Hendrix LH, Sun L, Tam I, Macsai M, Gibson AA. Matching-adjusted indirect comparison of phase 3 clinical trial outcomes: OC-01 (varenicline solution) nasal spray and cyclosporine a 0.05% ophthalmic emulsion for the treatment of dry eye disease. J Manag Care Spec Pharm. 2022 Aug; 28(8):892-902.
-
Scheetz SD, Upadhyay GA. Physiologic Pacing Targeting the His Bundle and Left Bundle Branch: a Review of the Literature. Curr Cardiol Rep. 2022 Aug; 24(8):959-978.
-
De Pooter J, Ozpak E, Calle S, Peytchev P, Heggermont W, Marchandise S, Provenier F, Francois B, Anné W, Pollet P, Barbraud C, Gillis K, Timmermans F, Van Heuverswyn F, Tung R, Wauters A, le Polain de Waroux JB. Initial experience of left bundle branch area pacing using stylet-driven pacing leads: A multicenter study. J Cardiovasc Electrophysiol. 2022 07; 33(7):1540-1549.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|